Abstract
The COVID-19 pandemic is both a global health crisis, and a civic emergency for national governments, including the UK. As countries across the world loosen their lockdown restrictions, the assumption is generally made that the risk of COVID-19 transmission is lower outdoors, and this assumption has shaped decisions about what activities can re-commence, the circumstances in which they should re-commence, and the conditions under which they should re-commence. This is important for events and activities that generate mass gatherings, particularly mass participation sports events such as running, but also events in other sectors such as concerts, carnivals and festivals.
This paper sets out a protocol for a rapid scoping review of evidence of incidents of outdoor transmission of COVID-19, including the settings, environments and circumstances of such transmission, and their comparative prevalence to incidents of indoor transmission.
Its purpose is to inform discussions about the recommencement of activities that generate mass gatherings.
Competing Interest Statement
MW is a member of the parkrun International Research Board, and regularly takes part in parkrun. This work is funded by parkrun.
Funding Statement
The work is funded by parkrun
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This is a protocol for a Rapid Scoping Review of Evidence. Ethical review (which we expect to result in an exemption as the review incorporates only secondary evidence sources) is currently pending with the Ethics Panel of the Faculty of Science, Engineering and Social Science at Canterbury Christ Church University.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
This is a protocol for a Rapid Scoping Review of Evidence. The data comprises the sources that will be returned in the review, all of which will be referenced and available for public scrutiny
